|
| | GINSENOSIDEF1 Basic information |
| Product Name: | GINSENOSIDEF1 | | Synonyms: | (20S)-20-(β-D-Glucopyranosyloxy)dammar-24-ene-3β,6α,12β-triol;3β,6α,12β-Trihydroxy-5α-dammar-24-en-20-yl β-D-glucopyranoside;(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside;Ginsenoside F1;GINSENOSIDE F1(P);20(S)-Ginsenoside F1(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl beta-D-glucopyranoside;20(S)-Ginsenoside F1;Panaxoside Aprogenin | | CAS: | 53963-43-2 | | MF: | C36H62O9 | | MW: | 638.87 | | EINECS: | | | Product Categories: | chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 53963-43-2.mol |  |
| | GINSENOSIDEF1 Chemical Properties |
| Melting point | >165°C (dec.) | | Boiling point | 751.7±60.0 °C(Predicted) | | density | 1.23±0.1 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | solubility | DMSO (Slightly), Methanol (Slightly ) | | pka | 12.94±0.70(Predicted) | | form | powder | | color | Pale Yellow | | Stability: | Hygroscopic |
| | GINSENOSIDEF1 Usage And Synthesis |
| Uses | Ginsenoside F1 is a bioactive metabolite of the ginsenoside component of Panax ginseng with the ability to inhibit human cytochrome P450 enzymes. This has application in anti-cancer therapeutics as well as protective liver effects. | | Definition | ChEBI: A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hy
roxy group at position 20 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. |
| | GINSENOSIDEF1 Preparation Products And Raw materials |
|
